HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS, AND METHODS OF USE THEREOF

Fri, 17 Apr 2026 23:23:51 +0000
Intellectual Property

The European Patent Office published patent application EP2023216237A1 for JS Innomed Holdings Ltd., covering heterocyclic compounds as kinase inhibitors, compositions, and methods of use. The A1 publication indicates the application has passed formal examination and is now open for opposition. The patent covers compounds classified under IPC C07D 471/04 with therapeutic applications in A61K 31/437 and A61P 35/00 (oncology). The designated states include all current EU member states plus associated countries.